CasLoc logo
All Cases PTAB Litigations UPC Oppositions

King Pharmaceuticals Research and Development, Inc. v. SICOR Inc.

1:05-cv-00337

Overview

Case Number 1:05-cv-00337
Filing Date 2005-05-26
Status Terminated
Termination Date 2007-10-29
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Pharmaceuticals Industries, LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

SICOR Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Doungamon Fon Muttamara-Walker

District of Columbia Office of

Tel: +1 (240) 447-9752

Administrative Hearings, 441 Fourth Street, N.W.

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

SICOR Inc. Operating Company

Represented By

2 Attorneys Listed

Doungamon Fon Muttamara-Walker

District of Columbia Office of

Tel: +1 (240) 447-9752

Administrative Hearings, 441 Fourth Street, N.W.

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Plaintiff

Astellas Pharma US, Inc. Operating Company

Represented By

1 Attorneys Listed

Richard K. Herrmann

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Astellas US LLC Operating Company

Represented By

1 Attorneys Listed

Richard K. Herrmann

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

King Pharmaceuticals Research and Development Inc. Operating Company

Represented By

7 Attorneys Listed

Patricia Smink Rogowski

Rogowski Law LLC

Tel: +1 (302) 893-0048

501 Silverside Road, Suite 11, Wilmington, DE 19809

Jonathan A. Muenkel

Pro Hac Vice

Pro Hac Vice

Gasper J. LaRosa

Email: GJLaRosa@jonesday.com

Francis D. Cerrito

Pro Hac Vice

Pro Hac Vice

Evangeline Shih

Email: evangelineshih@quinnemanuel.com

Brian M. Poissant

UNDELIVERABLE EMAIL 7/12/2018

Paul E. Crawford

Novak Druce Connolly Bove + Quigg LLP

Tel: +1 (302) 658-9141
Fax: +1 (302) 658-5614

The Nemours Building, 1007 North Orange Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): 🇨🇦 Canada 🇪🇺 Europe 🇯🇵 Japan 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5070877
Novel method of myocardial imaging
Filed: 1989-03-29
Issued: 1991-12-10
Expired (Term Ended) +50d PTA
Expires: 2009-05-18
US5731296
Selective vasodilation by continuous adenosine infusion
Filed: 1993-03-15
Issued: 1998-03-24
Expired (Term Ended)
Expires: 2013-03-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

17

Dispositive

7

Granted

0

Denied

2

Pending / Review

11

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 6 Motion to Dismiss 1 Procedural / Extension Motion 9 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Motion to Dismiss (FRCP 12(b)(6)) Moot / Terminated
MEMORANDUM AND ORDER, Motions terminated: Granting in part, denying in part 5 MOTION to Dismiss for Failure to State a Claim Defendants Sicor Pharmaceuticals, I...
Entry #79 • 2006-03-31 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending
Letter to Judge Robinson from Monte T. Squire regarding Citation of Subsequent Authorities - re 5 MOTION to Dismiss for Failure to State a Claim Defendants Sico...
Entry #66 • 2006-03-14 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
Letter to Judge Robinson from Monte T. Squire regarding Citation of Subsequent Authorities - re 5 MOTION to Dismiss for Failure to State a Claim Defendants Sico...
Entry #66 • 2006-03-14 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPLY BRIEF re 5 MOTION to Dismiss for Failure to State a Claim Defendant Sicor Pharmaceuticals, Inc.'s and Sicor Inc.'s Motion to Dismiss Count III of the Comp...
Entry #17 • 2005-09-06 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ANSWERING BRIEF in Opposition re 5 MOTION to Dismiss for Failure to State a Claim Defendant Sicor Pharmaceuticals, Inc.'s and Sicor Inc.'s Motion to Dismiss Cou...
Entry #15 • 2005-08-29 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to respond to Sicor's Motion to Dismiss to August 29, 2005 - filed by SICOR Inc., SICOR Pharmaceuticals, Inc., King Ph...
Entry #13 • 2005-08-17 Document →

Docket Entries

(132 total)
Pleading / Complaint

COMPLAINT filed against SICOR Inc., SICOR Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries, LTD. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 139430.) - filed by King Pharmaceuticals Research and Development, Inc., Astellas US LLC, Astellas Pharma US, Inc.. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(els, ) (Entered: 05/27/2005)

Entry #1 • 2005-05-26
1
Pleading / Complaint

COMPLAINT filed against SICOR Inc., SICOR Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries, LTD. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 139430.) - filed by King Pharmaceuticals Research and Development, Inc., Astellas US LLC, Astellas Pharma US, Inc.. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(els, ) (Entered: 05/27/2005)

Entry #1 • 2005-05-26
2
Pleading / Complaint

COMPLAINT filed against SICOR Inc., SICOR Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries, LTD. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 139430.) - filed by King Pharmaceuticals Research and Development, Inc., Astellas US LLC, Astellas Pharma US, Inc.. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(els, ) (Entered: 05/27/2005)

Entry #1 • 2005-05-26
2
Pleading / Complaint

COMPLAINT filed against SICOR Inc., SICOR Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries, LTD. - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 139430.) - filed by King Pharmaceuticals Research and Development, Inc., Astellas US LLC, Astellas Pharma US, Inc.. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(els, ) (Entered: 05/27/2005)

Entry #1 • 2005-05-26
2

Disclosure Statement pursuant to Rule 7.1 filed by Astellas US LLC, Astellas Pharma US, Inc. identifying Astellas US Holding, Inc. and Astellas Pharma Inc. as Corporate Parent. (els, ) (Entered: 05/27/2005)

Entry #2 • 2005-05-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc